Decreased liver type I 5'-deiodinase and increased brown adipose tissue type II 5'-deiodinase activity in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated Long-Evans rats

被引:25
作者
Raasmaja, A
Viluksela, M
Rozman, KK
机构
[1] UNIV KANSAS,MED CTR,DEPT PHARMACOL TOXICOL & THERAPEUT,KANSAS CITY,KS 66160
[2] UNIV HELSINKI,DEPT MED CHEM,INST BIOMED,FIN-00014 HELSINKI,FINLAND
[3] NATL PUBL HLTH INST,DEPT TOXICOL,DIV ENVIRONM HLTH,KUOPIO 70701,FINLAND
[4] GSF MUNICH,INST TOXIKOL,ENVIRONM TOXICOL SECT,D-85758 MUNICH,GERMANY
基金
芬兰科学院;
关键词
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD); Brown adipose tissue; liver; deiodinases; thyroid hormones;
D O I
10.1016/S0300-483X(96)03488-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) was studied on the activity of type I 5'-deiodinase (5' DI) in liver and of type II 5'-deiodinase (5' DII) in brown adipose tissue (BAT) microsomes of Long-Evans rats. TCDD decreased the activity of liver 5' DI and increased that of BAT 5' DII. It also reduced the concentration of serum total thyroxine (T-4) without affecting triiodothyronine (T-3). These effects of TCDD on 5'-deiodinases and serum thyroid hormones are compatible with partial hypothyroidism. Based on our results, it is not possible to decide unequivocally whether TCDD affects thyroid hormone status and 5'-deiodination by a direct action or a feedback mechanism. However, these data are important because they demonstrate that TCDD affects thyroid status in a tissue-specific manner and that its effects on thyroid hormone metabolism are much more complex than currently assumed.
引用
收藏
页码:199 / 205
页数:7
相关论文
共 31 条
[1]   TRIIODOTHYRONINE AND THYROXINE IN SERUM AND THYROID-GLANDS OF IODINE-DEFICIENT RATS [J].
ABRAMS, GM ;
LARSEN, PR .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (10) :2522-2531
[2]   ENHANCED THYROXINE METABOLISM AND HIGH UPTAKE GOITERS IN RATS AFTER A SINGLE DOSE OF 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN [J].
BASTOMSKY, CH .
ENDOCRINOLOGY, 1977, 101 (01) :292-296
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   THE THYROID-GLAND IS A MAJOR SOURCE OF CIRCULATING-T(3) IN THE RAT [J].
CHANOINE, JP ;
BRAVERMAN, LE ;
FARWELL, AP ;
SAFRAN, M ;
ALEX, S ;
DUBORD, S ;
LEONARD, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (06) :2709-2713
[5]   THE INTERACTION OF L-TRIIODOTHYRONINE AND 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN ON AH-RECEPTOR-MEDIATED HEPATIC PHASE-I AND PHASE-II ENZYMES AND IODOTHYRONINE 5'-DEIODINASE IN THYROIDECTOMIZED RATS [J].
ELTOM, SE ;
BABISH, JG ;
FERGUSON, DC .
TOXICOLOGY LETTERS, 1992, 61 (2-3) :125-139
[6]   DOSE-RESPONSE AND TIME COURSE OF HYPOTHYROXINEMIA AND HYPOINSULINEMIA AND CHARACTERIZATION OF INSULIN HYPERSENSITIVITY IN 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN (TCDD) TREATED RATS [J].
GORSKI, JR ;
ROZMAN, K .
TOXICOLOGY, 1987, 44 (03) :297-307
[7]   SOME ENDOCRINE AND MORPHOLOGICAL ASPECTS OF THE ACUTE TOXICITY OF 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN (TCDD) [J].
GORSKI, JR ;
MUZI, G ;
WEBER, LWD ;
PEREIRA, DW ;
ARCEO, RJ ;
IATROPOULOS, MJ ;
ROZMAN, K .
TOXICOLOGIC PATHOLOGY, 1988, 16 (03) :313-320
[8]   TISSUE-SPECIFIC ALTERATIONS OF DENOVO FATTY-ACID SYNTHESIS IN 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN (TCDD)-TREATED RATS [J].
GORSKI, JR ;
WEBER, LWD ;
ROZMAN, K .
ARCHIVES OF TOXICOLOGY, 1988, 62 (2-3) :146-151
[9]   CHANGES IN THYROID-HORMONES AND THYROXINE GLUCURONIDATION IN HAMSTERS COMPARED WITH RATS FOLLOWING TREATMENT WITH 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN [J].
HENRY, EC ;
GASIEWICZ, TA .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1987, 89 (02) :165-174
[10]   IODOTHYRONINE METABOLISM IN LIVER AND KIDNEY HOMOGENATES FROM HYPER-THYROID AND HYPOTHYROID RATS [J].
KAPLAN, MM ;
UTIGER, RD .
ENDOCRINOLOGY, 1978, 103 (01) :156-161